Delivery Order SPE2DB24D1104-SPE2DB24FXZE7
Award Date
6/13/24
Potential Completion Date
6/14/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,980.96 firm fixed price delivery order covers the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,364.74 firm-fixed-price delivery order contract is for the provision of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This award is under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award, valued at $2,041.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price contract. The award was not designated with a set-aside requirement, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $18,567.28 firm-fixed-price contract is for the supply of ADBRY 150 MG/ML syringes and has a period of performance through September 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military healthcare system. This award is likely part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,525.37, is for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of May 9, 2023. The contract is not designated with a set-aside, indicating open competition....
This federal contract award is for the delivery of medical supplies, specifically Adbry 150 mg/ml syringes, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,573.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of December 22, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,297.57 fixed-price delivery order contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of May 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the parent company of Amerisourcebergen Drug Corp Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award has a ceiling value of $26,800.98 and is for the product "ADBRY 150 MG/ML SYRINGEML". The contract is a firm fixed price delivery order with an ultimate completion date of August...
This federal contract award, valued at $15,473.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of ADBRY 150 MG/ML SYRINGEML, a medical supply item, with a completion date of February 2, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit pharmaceutical...
This federal contract award, valued at $4,301.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product ADBRY 150 MG/ML SYRINGEML, with a completion date of May 3, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...